Perfuze is a Biotech company based in Galway, Ireland. It has raised $54M in total funding. Latest round: Series A.
Perfuze funding overview
Perfuze is a Biotech company based in Galway, Ireland. Perfuze has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2022. The round record for Perfuze runs through 2022; nothing later has been disclosed. Investors on record include LSP, Seroba Life Sciences, SV Health Investors, Earlybird, Enterprise Ireland. 5 distinct backers are named across the disclosed rounds.
Perfuze at a glance
Total raised
$54M
Latest round
Series A
Latest round date
February 2022
Industry
Biotech
Headquarters
Galway, Ireland
Notable investors
LSP, Seroba Life Sciences, SV Health Investors, Earlybird, Enterprise Ireland
Frequently asked about Perfuze funding
How much has Perfuze raised?
Perfuze has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Perfuze?
LSP, Seroba Life Sciences, SV Health Investors, Earlybird, Enterprise Ireland are named among the investors backing Perfuze.
What was the latest Perfuze funding round?
The most recent disclosed round is a Series A, announced in February 2022.
Where is Perfuze based?
Perfuze is based in Galway, Ireland.
What sector does Perfuze operate in?
Perfuze is tracked under Biotech from Galway, Ireland, with $54M in disclosed funding.
When did Perfuze last raise?
The last disclosed Perfuze round closed in February 2022 at Series A.
Round data for Perfuze is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Galway and backer lists below.
